Benitec Biopharma Inc (BNTC)

Name: Benitec Biopharma Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$13.6M

Operating Margin

N/A

Free Cash Flow

-$23.6M

Debt / Assets

2.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Benitec Biopharma Inc (BNTC).
Income Statement (Quarterly)	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	0
Cost of Revenue	178,522	0	0	0
Gross Profit	-178,522	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	9,553,964	4,208,000	3,538,000	2,206,000
Operating Expenses	14,652,436	10,188,000	8,610,000	5,791,000
Operating Income	-14,830,958	-10,188,000	-8,610,000	-5,791,000
Interest Expense	0	823,000	0	0
Income Before Tax	-13,563,148	-9,354,000	-7,357,000	-5,059,000
Income Tax Expense	0	0	0	0
Net Income	-13,563,148	-9,354,000	-7,357,000	-5,059,000
Per Share
EPS	-0.22	-0.24	-0.33	-0.48
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Benitec Biopharma Inc (BNTC).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	0	0	75,000	73,000	59,000
Cost of Revenue	396,000	343,000	381,000	9,000	123,000
Gross Profit	-396,000	-343,000	-306,000	64,000	-64,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	23,433,000	6,646,000	6,382,000	6,646,000	6,512,000
Operating Expenses	41,369,000	22,255,000	18,775,000	17,918,000	13,532,000
Operating Income	-41,765,000	-22,598,000	-19,081,000	-17,854,000	-13,596,000
Interest Expense	0	0	33,000	32,000	-6,000
Income Before Tax	-37,917,000	-21,751,000	-19,562,000	-18,208,000	-13,882,000
Income Tax Expense	0	0	3,000	354,000	0
Net Income	-37,917,000	-21,751,000	-19,562,000	-18,562,000	-13,882,000
Per Share
EPS	-1.05	-2.68	-14.12	-38.62	-3.23
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Benitec Biopharma Inc (BNTC).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	97,744,000	50,866,000	2,477,000	4,062,000
Short Term Investments	0	0	0	0
Net Receivables	33,000	229,000	0	3,000
Inventory	0	0	13,000	2
Total Current Assets	98,518,000	51,674,000	3,729,000	4,820,000
Property Plant Equipment	991,000	449,000	613,000	993,000
Goodwill and Intangibles	0	0	0	0
Total Assets	99,592,000	52,210,000	4,464,000	5,973,000
Liabilities
Account Payables	201,000	1,351,000	1,140,000	1,880,000
Short Term Debt	354,000	568,000	275,000	252,000
Total Current Liabilities	1,802,000	4,924,000	3,978,000	2,532,000
Long Term Debt	495,000	0	284,000	559,000
Total Liabilities	2,297,000	4,962,000	4,262,000	3,091,000
Shareholders Equity
Retained Earnings	-228,176,000	-190,259,000	-167,889,000	-148,327,000
Total Shareholders Equity	97,295,000	47,248,000	202,000	2,882,000

Balance sheet annual history for Benitec Biopharma Inc (BNTC).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	97,744,000	50,866,000	2,477,000	4,062,000	19,769,000
Short Term Investments	0	0	0	0	0
Net Receivables	33,000	229,000	0	3,000	25,000
Inventory	0	0	13,000	2	0
Total Current Assets	98,518,000	51,674,000	3,729,000	4,820,000	20,608,000
Property Plant Equipment	991,000	449,000	613,000	993,000	577,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	99,592,000	52,210,000	4,464,000	5,973,000	21,379,000
Liabilities
Account Payables	201,000	1,351,000	1,140,000	1,880,000	274,000
Short Term Debt	354,000	568,000	275,000	252,000	213,000
Total Current Liabilities	1,802,000	4,924,000	3,978,000	2,532,000	1,369,000
Long Term Debt	495,000	0	284,000	559,000	0
Total Liabilities	2,297,000	4,962,000	4,262,000	3,091,000	1,369,000
Shareholders Equity
Retained Earnings	-228,176,000	-190,259,000	-167,889,000	-148,327,000	-130,119,000
Total Shareholders Equity	97,295,000	47,248,000	202,000	2,882,000	20,010,000

Cash flow quarterly history for Benitec Biopharma Inc (BNTC).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-37,917,000	-21,751,000	-19,562,000	-18,208,000
Depreciation & Amortization	396,000	343,000	381,000	392,000
Stock Based Compensation	17,426,000	830,000	452,000	870,000
Change in Working Capital	-2,729,000	1,174,000	714,000	1,037,000
Operating Cash Flow	-23,588,000	-19,403,000	-18,012,000	-15,899,000
Investing Activities
Capital Expenditure	-18,000	-179,000	-1,000	-13,000
Investments	-18,000	-179,000	-1,000	-13,000
Investing Cash Flow	-18,000	-179,000	-1,000	-13,000
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	70,485,000	73,921,000	17,884,000	0
Dividends Paid	0	0	0	0
Financing Cash Flow	70,485,000	68,029,000	16,015,000	0
Summary
Free Cash Flow	-23,606,000	-19,582,000	-18,013,000	-15,912,000
Net Change in Cash	46,928,000	48,439,000	-1,586,000	-15,708,000

Cash flow annual history for Benitec Biopharma Inc (BNTC).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-37,917,000	-21,751,000	-19,562,000	-18,208,000	-13,882,000
Depreciation & Amortization	396,000	343,000	381,000	392,000	424,000
Stock Based Compensation	17,426,000	830,000	452,000	870,000	634,000
Change in Working Capital	-2,729,000	1,174,000	714,000	1,037,000	8,000
Operating Cash Flow	-23,588,000	-19,403,000	-18,012,000	-15,899,000	-12,832,000
Investing Activities
Capital Expenditure	-18,000	-179,000	-1,000	-13,000	-221,000
Investments	-18,000	-179,000	-1,000	-13,000	-221,000
Investing Cash Flow	-18,000	-179,000	-1,000	-13,000	-221,000
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	70,485,000	73,921,000	17,884,000	0	25,750,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	70,485,000	68,029,000	16,015,000	0	22,522,000
Summary
Free Cash Flow	-23,606,000	-19,582,000	-18,013,000	-15,912,000	-13,053,000
Net Change in Cash	46,928,000	48,439,000	-1,586,000	-15,708,000	9,968,000